The Industry-Academia Collaborative Mission, a pan-India programme, would focus on preparing India's technological and product development capabilities in the biopharmaceutical sector to a level that it is globally competitive over the next 10-15 years.
The mission will also lay emphasis on the development of vaccines, biotherapeutics, medical devices and diagnostics; establishment of shared infrastructure and facilities; building and strengthening domain specific knowledge and management skills; creating and enhancing technology transfer capabilities in the public and private sector.
It will also aim to transform the health standards of India's population through affordable product development.